Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Vimizim739.78M25.92%
Voxzogo735.09M25.76%
Naglazyme479.58M16.80%
Palynziq355.05M12.44%
ALDURAZYME183.89M6.44%
Brineura169.08M5.92%
Kuvan120.9M4.24%
Royalty and other revenues44.47M1.56%
ROCTAVIAN26.07M0.91%
View all
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States924.81M32.40%
Europe829.03M29.05%
Rest of world493.63M17.30%
Latin America378.08M13.25%
Aldurazyme net product revenues marketed by Sanofi183.89M6.44%
Royalty and other revenues44.47M1.56%
View all